BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 3121748)

  • 21. Effect of cisplatin, lipopolysaccharide, muramyl dipeptide and recombinant interferon-gamma on murine macrophages in vitro. I. Macrophage-mediated tumor cell lysis.
    Geetha B; Sodhi A
    Nat Immun Cell Growth Regul; 1989; 8(2):100-7. PubMed ID: 2503714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential requirement of a functional double-stranded RNA-dependent protein kinase (PKR) for the tumoricidal activation of macrophages by lipopolysaccharide or IFN-alpha beta, but not IFN-gamma.
    Gusella GL; Musso T; Rottschafer SE; Pulkki K; Varesio L
    J Immunol; 1995 Jan; 154(1):345-54. PubMed ID: 7995954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High strength binding of P815 mastocytoma cells is not necessary for their lysis by macrophages which have been primed and triggered in vitro.
    Lu CY; Lombardi MJ; Shea CM; Dustin LB
    J Immunol; 1988 Aug; 141(4):1083-90. PubMed ID: 3135320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumoricidal activation of murine resident peritoneal macrophages by interleukin 2 and tumor necrosis factor alpha.
    Verstovsek S; Maccubbin D; Ehrke MJ; Mihich E
    Cancer Res; 1992 Jul; 52(14):3880-5. PubMed ID: 1617664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibronectin activates murine peritoneal macrophages for tumor cell destruction in the presence of IFN-gamma.
    Jun CD; Yoon HJ; Kim HM; Chung HT
    Biochem Biophys Res Commun; 1995 Jan; 206(3):969-74. PubMed ID: 7832812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of C3H/HeJ macrophage tumoricidal activity and cytokine release by R-chemotype lipopolysaccharide preparations. Differential effects of IFN-gamma.
    Flebbe LM; Chapes SK; Morrison DC
    J Immunol; 1990 Sep; 145(5):1505-11. PubMed ID: 2117032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo and in vitro activation of alveolar macrophages by recombinant interferon-gamma.
    Black CM; Catterall JR; Remington JS
    J Immunol; 1987 Jan; 138(2):491-5. PubMed ID: 3098846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing.
    Pace JL; Russell SW; Torres BA; Johnson HM; Gray PW
    J Immunol; 1983 May; 130(5):2011-3. PubMed ID: 6403616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inability of recombinant interferon-gamma to activate the antibacterial activity of mouse peritoneal macrophages against Listeria monocytogenes and Salmonella typhimurium.
    van Dissel JT; Stikkelbroeck JJ; Michel BC; van den Barselaar MT; Leijh PC; van Furth R
    J Immunol; 1987 Sep; 139(5):1673-8. PubMed ID: 2957433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phorbol esters and calcium ionophore can prime murine peritoneal macrophages for tumor cell destruction.
    Somers SD; Weiel JE; Hamilton TA; Adams DO
    J Immunol; 1986 Jun; 136(11):4199-205. PubMed ID: 2422276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
    Fogler WE; Talmadge JE; Fidler IJ
    J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma.
    Stuehr DJ; Marletta MA
    J Immunol; 1987 Jul; 139(2):518-25. PubMed ID: 3110273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trace levels of bacterial lipopolysaccharide prevent interferon-gamma or tumor necrosis factor-alpha from enhancing mouse peritoneal macrophage respiratory burst capacity.
    Ding AH; Nathan CF
    J Immunol; 1987 Sep; 139(6):1971-7. PubMed ID: 3040860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IFN-gamma mediates increased glucocorticoid receptor expression in murine macrophages.
    Salkowski CA; Vogel SN
    J Immunol; 1992 May; 148(9):2770-7. PubMed ID: 1315358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella.
    Schafer R; Nacy CA; Eisenstein TK
    J Immunol; 1988 Mar; 140(5):1638-44. PubMed ID: 3279120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of nitric oxide produced by activated macrophages in their cytocidal activity against glial tumor cells].
    Akiyama Y; Yamasaki T; Fukuda M; Moritake K
    No To Shinkei; 1995 Apr; 47(4):349-55. PubMed ID: 7772402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of allogenic Dalton's lymphoma cells on the activation of murine peritoneal macrophages to tumoricidal state by cisplatin and lipopolysaccharide (LPS).
    Singh SM; Singh RK; Sodhi A
    Neoplasma; 1992; 39(3):151-5. PubMed ID: 1528319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha.
    Heidenreich S; Weyers M; Gong JH; Sprenger H; Nain M; Gemsa D
    J Immunol; 1988 Mar; 140(5):1511-8. PubMed ID: 3126228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of interferon-gamma on cytotoxicity of murine activated macrophages against murine glioma cells].
    Ohyama K; Kikuchi H; Oda Y; Moritake K; Yamasaki T
    No To Shinkei; 1993 Jun; 45(6):525-30. PubMed ID: 8363848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.